Fluticasone propionate, salmeterol (as xinafoate); 45mcg/21mcg ... Trial 4: Clinical Trial with Advair HFA 230 mcg/21 mcg A active-controlled, 12-week, non-US trial compared Advair HFA 230 ...
Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP) combination product (50/100µg twice daily) with budesonide (BUD) at a four-fold higher microgram ...
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback